BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10658480)

  • 1. [Malignant lymphoma with c-myc gene rearrangement in a patient receiving long-term treatment for multiple myeloma].
    Ohnishi H; Kamimura T; Gondo H; Okamura T; Niho Y; Yao T
    Rinsho Ketsueki; 1999 Dec; 40(12):1265-70. PubMed ID: 10658480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
    Takai K; Sanada M; Hirose Y; Shibuya H
    Rinsho Ketsueki; 1997 Sep; 38(9):757-62. PubMed ID: 9364867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
    Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
    Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
    Wang HY; Bossler AD; Schaffer A; Tomczak E; DiPatri D; Frank DM; Nowell PC; Bagg A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):45-53. PubMed ID: 17175379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary splenic lymphoma with t(3;14)(q27;q32) chromosomal abnormality and rearrangement of BCL-6 gene].
    Yata K; Wada H; Otsuki T; Sadahira Y; Sugihara T; Yamada O; Yawata Y
    Rinsho Ketsueki; 1999 Jul; 40(7):587-92. PubMed ID: 10483143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute lymphoblastic leukemia (L3) with t(2;3)(p12;q27), t(14;18)(q32;q21), and t(8;22)(q24;q11)].
    Fujii S; Miyata A; Takeuchi M; Yoshino T
    Rinsho Ketsueki; 2005 Feb; 46(2):134-40. PubMed ID: 16447707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma.
    Niitsu N; Okamoto M; Yoshino T; Nakamine H; Nakamura N; Bessho M; Hirano M; Miura I
    Leuk Res; 2007 May; 31(5):707-11. PubMed ID: 16887184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary effusion lymphoma of the pericardial cavity carrying t(1;22)(q21;q11) and t(14;17)(q32;q23).
    Fujiwara T; Ichinohasama R; Miura I; Sugawara T; Harigae H; Yokoyama H; Takahashi S; Tomiya Y; Yamada M; Ishizawa K; Kameoka J; Sasaki T
    Cancer Genet Cytogenet; 2005 Jan; 156(1):49-53. PubMed ID: 15588855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8;14)(q24;q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus.
    Stejskalova E; Jarosova M; Kabickova E; Smelhaus V; Mrhalova M; Kodet R
    Cancer Genet Cytogenet; 2006 Oct; 170(2):158-62. PubMed ID: 17011988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
    Tzankov A; Höllrigl A; Verdorfer I; Oxle H
    Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch.
    Mannouji K; Tasaka T; Akiyama T; Irei I; Sano F; Matsuhashi Y; Wada H; Tohyama K; Sugihara T; Sadahira Y
    Pathol Int; 2009 Apr; 59(4):261-4. PubMed ID: 19351371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.
    Young KH; Xie Q; Zhou G; Eickhoff JC; Sanger WG; Aoun P; Chan WC
    Am J Clin Pathol; 2008 Jan; 129(1):157-66. PubMed ID: 18089500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.
    Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R
    Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
    Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
    Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21).
    Nguyen JC; Kubik MJ; Broome HE; Curtin PT; Dell'Aquila ML; Wang HY
    Pathol Res Pract; 2015 Nov; 211(11):883-91. PubMed ID: 26300063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.